Evidence map›Paper›PMID 40337642›Full record

ArticleFrontiers in molecular biosciences2025

Successful prediction of LC8 binding to intrinsically disordered proteins sheds light on AlphaFold's black box.

Douglas R Walker, Gretchen Fujimura, Juan M Vanegas, Elisar J Barbar

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Douglas R WalkerDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.
Gretchen FujimuraDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.
Juan M VanegasDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.
Elisar J BarbarDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: LC8 is a hub protein involved in many processes from tumor suppression and cell cycle regulation to neurotransmission and viral infection. Despite recent progress, prediction of binding sites for LC8 is plagued by motif variability and a multitude of weakly binding motifs, especially when binding depends on multivalency. Our binding site prediction algorithm, LC8Pred has proven useful for uncovering new LC8 binders, but is insufficient for finding all LC8 binding sites. Methods: To address this, we probed the ability of a general structure predictor, AlphaFold, to predict whether a given sequence binds to LC8. Certain combinations of in-built AlphaFold scores were extracted and distributions of scores of binders were compared to scores of nonbinders. Results: AlphaFold successfully places proteins at the correct interface of LC8. A set of threshold values of built-in AlphaFold scores enables differentiation between known binders and nonbinders with minimal false positive (8%) and acceptable false negative rates (20%). This cutoff, along with a more inclusive cutoff, was used to predict elusive LC8 binding sites in proteins known to bind LC8. Discussion: Correlations between binding affinities and AlphaFold scores provide insight into the black box and indicate that AlphaFold learned an inaccurate energy function that nevertheless is useful for making inferences and conclusions about physical systems. Binding sites predicted by this method can be prioritized for investigation by comparing to result by LC8Pred, local structure, and evolutionary conservation.

Indexed as

AlphaFold 2binding predictionsexplain AIhub proteinintrinsic disorderLC8 dynein light chainprotein binding

Identifiers

PMID40337642
PMCPMC12057147

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.